Welcome to this FDA/CMS Summit for Payers podcast.Below is a teaser from our podcast with Bill Winkenwerder, Former CEO, Highmark Inc.
How should manufacturers determine drug prices and what consideration should there be?
Bill: Well, certainly manufacturers need to recover their costs – their investment in R&D – and it’s important that they make a profit. Nobody can be in business for any period of time without being able to make a profit. Now, more recently – especially with respect to certain manufacturers that have brought very expensive medications to the market – have been criticized and have been identified as charging too much. That’s the common perception, but I see the immediate evidence that the prices for these medications – given the relatively small population of people that would benefit from them – that there is a serious over-charging that’s going on. But, certainly we need to sit down and talk and determine if there is a better way to arrive at the price. What is a fair price? What is a good, market-based price? That’s what this Conference is about.
To see more from Dr. Winkenwerder, download the complete podcast here.
Download the updated event brochure here.
Bill will be joining us at the FDA/CMS Summit for Payers in Washington D.C. for his closing keynote address "An Industry Perspective: Payment Policy for Clinically Valuable But Very Expensive Pharmaceuticals" on Friday December 12th.
Register now to save an extra $100 off the current rate with the code XP1917BLOG.
See you in Washington D.C.
No comments:
Post a Comment